$TRU
TransUnion

2021 Q2 Form 10-Q Financial Statement

#000155203321000046 Filed on July 27, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2
Revenue $728.2M $587.1M
YoY Change 24.03% -11.3%
Cost Of Revenue $234.7M $218.6M
YoY Change 7.37% 1.11%
Gross Profit $493.5M $415.8M
YoY Change 18.69% -6.71%
Gross Profit Margin 67.77% 70.82%
Selling, General & Admin $199.8M $201.1M
YoY Change -0.65% 2.24%
% of Gross Profit 40.49% 48.36%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $98.40M $90.90M
YoY Change 8.25% 1.91%
% of Gross Profit 19.94% 21.86%
Operating Expenses $527.7M $510.5M
YoY Change 3.37% 1.65%
Operating Profit $200.4M $106.0M
YoY Change 89.06% -33.63%
Interest Expense $25.60M $33.50M
YoY Change -23.58% -25.88%
% of Operating Profit 12.77% 31.6%
Other Income/Expense, Net -$19.70M -$30.90M
YoY Change -36.25% 130.6%
Pretax Income $180.7M $93.00M
YoY Change 94.3% -36.43%
Income Tax $58.60M $23.00M
% Of Pretax Income 32.43% 24.73%
Net Earnings $127.6M $68.50M
YoY Change 86.28% -32.51%
Net Earnings / Revenue 17.52% 11.67%
Basic Earnings Per Share $0.67 $0.36
Diluted Earnings Per Share $0.66 $0.36
COMMON SHARES
Basic Shares Outstanding 191.4M shares 189.9M shares
Diluted Shares Outstanding 192.8M shares 192.0M shares

Balance Sheet

Concept 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $529.4M $490.9M
YoY Change 7.84% 103.19%
Cash & Equivalents $526.2M $432.2M
Short-Term Investments $3.200M $58.70M
Other Short-Term Assets $215.0M $199.4M
YoY Change 7.82% 7.38%
Inventory
Prepaid Expenses $120.6M $88.10M
Receivables $511.8M $433.1M
Other Receivables $0.00 $37.90M
Total Short-Term Assets $1.253B $1.065B
YoY Change 17.69% 22.44%
LONG-TERM ASSETS
Property, Plant & Equipment $209.3M $203.3M
YoY Change 2.95% -5.49%
Goodwill $3.455B $3.281B
YoY Change 5.32% -2.14%
Intangibles $2.211B $2.247B
YoY Change -1.6% -8.26%
Long-Term Investments $44.00M $38.60M
YoY Change 13.99% -11.67%
Other Assets $266.2M $229.2M
YoY Change 16.14% -4.78%
Total Long-Term Assets $6.142B $5.960B
YoY Change 3.05% -4.75%
TOTAL ASSETS
Total Short-Term Assets $1.253B $1.065B
Total Long-Term Assets $6.142B $5.960B
Total Assets $7.395B $7.025B
YoY Change 5.27% -1.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $212.2M $198.0M
YoY Change 7.17% 10.8%
Accrued Expenses $44.50M $28.60M
YoY Change 55.59% 11.28%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $69.30M $55.70M
YoY Change 24.42% -35.53%
Total Short-Term Liabilities $601.8M $582.2M
YoY Change 3.37% 1.13%
LONG-TERM LIABILITIES
Long-Term Debt $3.273B $3.573B
YoY Change -8.4% -6.74%
Other Long-Term Liabilities $181.8M $231.1M
YoY Change -21.33% 53.76%
Total Long-Term Liabilities $3.455B $3.805B
YoY Change -9.19% -4.45%
TOTAL LIABILITIES
Total Short-Term Liabilities $601.8M $582.2M
Total Long-Term Liabilities $3.455B $3.805B
Total Liabilities $4.488B $4.789B
YoY Change -6.29% -4.59%
SHAREHOLDERS EQUITY
Retained Earnings $1.160B $761.7M
YoY Change 52.3% 50.5%
Common Stock $2.136B $2.058B
YoY Change 3.76% 4.05%
Preferred Stock
YoY Change
Treasury Stock (at cost) $249.2M $212.2M
YoY Change 17.44% 19.82%
Treasury Stock Shares 5.600M shares 5.200M shares
Shareholders Equity $2.805B $2.139B
YoY Change
Total Liabilities & Shareholders Equity $7.395B $7.025B
YoY Change 5.27% -1.43%

Cashflow Statement

Concept 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income $127.6M $68.50M
YoY Change 86.28% -32.51%
Depreciation, Depletion And Amortization $98.40M $90.90M
YoY Change 8.25% 1.91%
Cash From Operating Activities $235.7M $253.9M
YoY Change -7.17% 43.28%
INVESTING ACTIVITIES
Capital Expenditures -$53.90M -$45.60M
YoY Change 18.2% -1.08%
Acquisitions
YoY Change
Other Investing Activities -$20.30M -$45.40M
YoY Change -55.29% 320.37%
Cash From Investing Activities -$74.20M -$91.00M
YoY Change -18.46% 59.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -70.30M -37.10M
YoY Change 89.49% -70.88%
NET CHANGE
Cash From Operating Activities 235.7M 253.9M
Cash From Investing Activities -74.20M -91.00M
Cash From Financing Activities -70.30M -37.10M
Net Change In Cash 91.20M 125.8M
YoY Change -27.5% -1871.83%
FREE CASH FLOW
Cash From Operating Activities $235.7M $253.9M
Capital Expenditures -$53.90M -$45.60M
Free Cash Flow $289.6M $299.5M
YoY Change -3.31% 34.12%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001552033
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000.0 shares
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000.0 shares
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37470
dei Entity Registrant Name
EntityRegistrantName
TransUnion
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
61-1678417
dei Entity Address Address Line1
EntityAddressAddressLine1
555 West Adams,
dei Entity Address City Or Town
EntityAddressCityOrTown
Chicago,
dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60661
dei City Area Code
CityAreaCode
312
dei Local Phone Number
LocalPhoneNumber
985-2000
dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value
dei Trading Symbol
TradingSymbol
TRU
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
191500000 shares
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
526200000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
493000000.0 USD
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
24800000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
26600000 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
511800000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
453700000 USD
CY2021Q2 us-gaap Other Assets Current
OtherAssetsCurrent
215000000.0 USD
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
159500000 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
1253000000.0 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
1106200000 USD
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
601400000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
548900000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
2804700000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
209300000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
223200000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
3455300000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
3461500000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1885400000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1752200000 USD
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2211300000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2284600000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
266200000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
236100000 USD
CY2021Q2 us-gaap Assets
Assets
7395100000 USD
CY2020Q4 us-gaap Assets
Assets
7311600000 USD
CY2021Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
212200000 USD
CY2020Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
193200000 USD
CY2021Q2 us-gaap Debt Current
DebtCurrent
69300000 USD
CY2020Q4 us-gaap Debt Current
DebtCurrent
55500000 USD
CY2021Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
320300000 USD
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
415800000 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
601800000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
664500000 USD
CY2021Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3273200000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3398700000 USD
CY2021Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
430700000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
396800000 USD
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
181800000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
215500000 USD
CY2021Q2 us-gaap Liabilities
Liabilities
4487500000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
4675500000 USD
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000.0 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
197100000 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
195700000 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
2540200000 USD
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
191500000 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
190500000 shares
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
2000000.0 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
2000000.0 USD
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2133700000 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2088100000 USD
CY2021Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
5600000 shares
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
5200000 shares
CY2021Q2 us-gaap Treasury Stock Value
TreasuryStockValue
249200000 USD
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
215200000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1160100000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
937400000 USD
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-241900000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-272100000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
435100000 USD
CY2021Q2 us-gaap Minority Interest
MinorityInterest
102900000 USD
CY2020Q4 us-gaap Minority Interest
MinorityInterest
95900000 USD
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2907600000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2636100000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7395100000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7311600000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
774200000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
634400000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1519500000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1322000000.0 USD
CY2021Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
250300000 USD
CY2020Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
218600000 USD
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
493500000 USD
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
443700000 USD
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
208000000.0 USD
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
201100000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
436400000 USD
CY2021Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
98400000 USD
CY2020Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
90800000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
192700000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
181200000 USD
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
556700000 USD
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
510500000 USD
us-gaap Operating Expenses
OperatingExpenses
1121300000 USD
us-gaap Operating Expenses
OperatingExpenses
1061300000 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
217500000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
123900000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
398200000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
260700000 USD
CY2021Q2 us-gaap Interest Expense
InterestExpense
25600000 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
33500000 USD
us-gaap Interest Expense
InterestExpense
51400000 USD
us-gaap Interest Expense
InterestExpense
71100000 USD
CY2021Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
900000 USD
CY2020Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1100000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
1500000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
3000000.0 USD
CY2021Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2700000 USD
CY2020Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2100000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
5700000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
4600000 USD
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-100000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-700000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-500000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7700000 USD
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-22100000 USD
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-30900000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-44600000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-71200000 USD
CY2021Q2 us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
195400000 USD
CY2020Q2 us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
93000000.0 USD
us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
353500000 USD
us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
189600000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
62500000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23000000.0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
90000000.0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
45200000 USD
CY2021Q2 us-gaap Profit Loss
ProfitLoss
132900000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
70000000.0 USD
us-gaap Profit Loss
ProfitLoss
263500000 USD
us-gaap Profit Loss
ProfitLoss
144300000 USD
CY2021Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
5200000 USD
CY2020Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1500000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
8000000.0 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
5600000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
127600000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
68500000 USD
us-gaap Net Income Loss
NetIncomeLoss
255600000 USD
us-gaap Net Income Loss
NetIncomeLoss
138700000 USD
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
191400000 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
189900000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
191200000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
189600000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
192800000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
192000000.0 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
192800000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
192000000.0 shares
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.67
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.34
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.73
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.66
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.36
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.33
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.72
CY2021Q2 us-gaap Profit Loss
ProfitLoss
132900000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
70000000.0 USD
us-gaap Profit Loss
ProfitLoss
263500000 USD
us-gaap Profit Loss
ProfitLoss
144300000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
15200000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
3900000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
4300000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-179100000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
300000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-1600000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-2000000.0 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
14900000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
5500000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
4300000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-177100000 USD
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
0 USD
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
4500000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
0 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
4100000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Before Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax
4800000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Before Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax
-12800000 USD
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Before Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax
33100000 USD
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Before Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax
-59700000 USD
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax
1200000 USD
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax
-2100000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax
8200000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax
-13800000 USD
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
3600000 USD
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-6200000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
24900000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-41800000 USD
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
100000 USD
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
0 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
100000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
0 USD
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0 USD
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0 USD
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
100000 USD
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
100000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
18600000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-700000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
29300000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-218900000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
151500000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
69300000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
292800000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-74600000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
5400000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
1400000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
7100000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
3800000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
146100000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
67900000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
285700000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-78400000 USD
us-gaap Profit Loss
ProfitLoss
263500000 USD
us-gaap Profit Loss
ProfitLoss
144300000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
192700000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
181200000 USD
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-600000 USD
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-500000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
23800000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-11200000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
34600000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
21500000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
600000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
10300000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
3100000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
7500000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
58300000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12500000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
33800000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
7500000 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
12800000 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
28800000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-59100000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
16500000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
380500000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
379400000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
97100000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
87600000 USD
us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
4100000 USD
us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
24700000 USD
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
21100000 USD
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
50700000 USD
us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
31400000 USD
us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
5200000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
600000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-2300000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-146100000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-116500000 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
113300000 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
31200000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
11100000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
12900000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
33300000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
29000000.0 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
34000000.0 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
33100000 USD
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
32400000 USD
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
6400000 USD
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
600000 USD
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-202500000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-86800000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
1300000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-18000000.0 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
33200000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
158100000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
493000000.0 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
274100000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
526200000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
432200000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements and related disclosures in accordance with GAAP requires management to make estimates and judgments that affect the amounts reported. We believe that the estimates used in preparation of the accompanying consolidated financial statements are reasonable, based upon information available to management at this time. These estimates and judgments affect the reported amounts of assets, liabilities and disclosure of contingent assets and liabilities at the balance sheet date, as well as the amounts of revenue and expense during the reporting period. Estimates are inherently uncertain and actual results could differ materially from the estimated amounts.</span></div>
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
26600000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
19000000.0 USD
us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
600000 USD
us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
10300000 USD
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
2400000 USD
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
3400000 USD
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
24800000 USD
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
26000000.0 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
41200000 USD
CY2021Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
120600000 USD
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
84700000 USD
CY2021Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
3200000 USD
CY2020Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
3200000 USD
CY2021Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
1600000 USD
CY2020Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
1800000 USD
CY2021Q2 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
89600000 USD
CY2020Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
69800000 USD
CY2021Q2 us-gaap Other Assets Current
OtherAssetsCurrent
215000000.0 USD
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
159500000 USD
CY2021Q2 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
168300000 USD
CY2020Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
138800000 USD
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
61600000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
65600000 USD
CY2021Q2 us-gaap Interest Rate Derivative Assets At Fair Value
InterestRateDerivativeAssetsAtFairValue
100000 USD
CY2020Q4 us-gaap Interest Rate Derivative Assets At Fair Value
InterestRateDerivativeAssetsAtFairValue
0 USD
CY2021Q2 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
36200000 USD
CY2020Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
31700000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
266200000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
236100000 USD
CY2021Q2 us-gaap Equity Method Investments
EquityMethodInvestments
44000000.0 USD
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
46100000 USD
CY2021Q2 ck0001552033 Nonmarketableequitysecurities
Nonmarketableequitysecurities
124300000 USD
CY2020Q4 ck0001552033 Nonmarketableequitysecurities
Nonmarketableequitysecurities
92700000 USD
CY2021Q2 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
168300000 USD
CY2020Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
138800000 USD
CY2021Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2700000 USD
CY2020Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2100000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
5700000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
4600000 USD
CY2021Q2 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
7400000 USD
CY2020Q2 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
5700000 USD
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
8000000.0 USD
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
6400000 USD
CY2021Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
130200000 USD
CY2020Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
149300000 USD
CY2021Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
83600000 USD
CY2020Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
85500000 USD
CY2021Q2 us-gaap Litigation Reserve Current
LitigationReserveCurrent
46700000 USD
CY2020Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
76000000.0 USD
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
15300000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
17900000 USD
CY2021Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
0 USD
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
37800000 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
44500000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
49300000 USD
CY2021Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
320300000 USD
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
415800000 USD
CY2021Q2 us-gaap Interest Rate Derivative Liabilities At Fair Value
InterestRateDerivativeLiabilitiesAtFairValue
56700000 USD
CY2020Q4 us-gaap Interest Rate Derivative Liabilities At Fair Value
InterestRateDerivativeLiabilitiesAtFairValue
89700000 USD
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
54700000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
54000000.0 USD
CY2021Q2 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
35500000 USD
CY2020Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
34400000 USD
CY2021Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
2000000.0 USD
CY2020Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3000000.0 USD
CY2021Q2 ck0001552033 Other Noncurrent Other Liabilities
OtherNoncurrentOtherLiabilities
32900000 USD
CY2020Q4 ck0001552033 Other Noncurrent Other Liabilities
OtherNoncurrentOtherLiabilities
34400000 USD
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
181800000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
215500000 USD
CY2021Q2 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
3342500000 USD
CY2020Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
3454200000 USD
CY2021Q2 us-gaap Debt Current
DebtCurrent
69300000 USD
CY2020Q4 us-gaap Debt Current
DebtCurrent
55500000 USD
CY2021Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3273200000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3398700000 USD
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
85000000.0 USD
us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
500000 USD
CY2021Q2 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
100000 USD
CY2021Q2 ck0001552033 Incremental Borrowings Amount
IncrementalBorrowingsAmount
1000000000.0 USD
CY2021Q2 ck0001552033 Incremental Borrowings Criteria Percentageof Consolidated Ebitda
IncrementalBorrowingsCriteriaPercentageofConsolidatedEBITDA
1
CY2021Q2 ck0001552033 Incremental Borrowings Criteria Senior Secured Leverageratio
IncrementalBorrowingsCriteriaSeniorSecuredLeverageratio
4.25
CY2021Q2 ck0001552033 Net Leverage Ratio Requirement
NetLeverageRatioRequirement
5.5
CY2021Q2 ck0001552033 Covenant Dividend Restriction Amount
CovenantDividendRestrictionAmount
75000000 USD
CY2021Q2 ck0001552033 Covenant Dividend Restriction Percentageof Consolidated Ebitda
CovenantDividendRestrictionPercentageofConsolidatedEBITDA
0.075
CY2021Q2 ck0001552033 Net Leverage Ratio Requirement Dividends
NetLeverageRatioRequirementDividends
4.75
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.075
CY2021Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.095
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.075
CY2021Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.095
CY2021Q1 us-gaap Dividends Payable Date Declared Day Month And Year
DividendsPayableDateDeclaredDayMonthAndYear
2021-02-24
CY2021Q2 us-gaap Dividends Payable Date Declared Day Month And Year
DividendsPayableDateDeclaredDayMonthAndYear
2021-05-11
CY2021Q1 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2021-03-11
CY2021Q2 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2021-05-26
CY2021Q1 us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2021-03-26
CY2021Q2 us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2021-06-10
CY2017Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
300000000.0 USD
us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P3Y
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
133500000 shares
CY2021Q2 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
166500000 USD
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
27700000 USD
CY2020Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
32100000 USD
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000.0 shares
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
ck0001552033 Numberof Typesof Performance Obligations
NumberofTypesofPerformanceObligations
2
CY2021Q2 us-gaap Profit Loss
ProfitLoss
132900000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
70000000.0 USD
us-gaap Profit Loss
ProfitLoss
263500000 USD
us-gaap Profit Loss
ProfitLoss
144300000 USD
CY2021Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
5200000 USD
CY2020Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1500000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
8000000.0 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
5600000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
127600000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
68500000 USD
us-gaap Net Income Loss
NetIncomeLoss
255600000 USD
us-gaap Net Income Loss
NetIncomeLoss
138700000 USD
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
191400000 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
189900000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
191200000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
189600000 shares
CY2021Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1400000 shares
CY2021Q2 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-5500000 USD
CY2020Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2100000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1600000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2500000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
192800000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
192000000.0 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
192800000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
192000000.0 shares
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.67
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.34
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.73
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.66
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.36
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.33
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.72
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.320
CY2021Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021Q2 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-2100000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.255
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-11200000 USD
us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-7900000 USD
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.247
CY2020Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020Q2 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-4700000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.239
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-21000000.0 USD
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
39300000 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
36900000 USD
CY2021Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
19600000 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
18500000 USD
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
5700000 USD
ck0001552033 Numberof Corporate Units
NumberofCorporateUnits
1 segment
CY2020 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
4800000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
774200000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
634400000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1519500000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1322000000.0 USD
CY2021Q2 ck0001552033 Segments Adjusted Ebitda
SegmentsAdjustedEBITDA
346400000 USD
CY2020Q2 ck0001552033 Segments Adjusted Ebitda
SegmentsAdjustedEBITDA
270400000 USD
ck0001552033 Segments Adjusted Ebitda
SegmentsAdjustedEBITDA
675200000 USD
ck0001552033 Segments Adjusted Ebitda
SegmentsAdjustedEBITDA
559500000 USD
CY2021Q2 ck0001552033 Adjusted Ebitda Adjustment Corporate Expense
AdjustedEBITDAAdjustmentCorporateExpense
27900000 USD
CY2020Q2 ck0001552033 Adjusted Ebitda Adjustment Corporate Expense
AdjustedEBITDAAdjustmentCorporateExpense
27700000 USD
ck0001552033 Adjusted Ebitda Adjustment Corporate Expense
AdjustedEBITDAAdjustmentCorporateExpense
56200000 USD
ck0001552033 Adjusted Ebitda Adjustment Corporate Expense
AdjustedEBITDAAdjustmentCorporateExpense
53500000 USD
CY2021Q2 ck0001552033 Adjusted Ebitda Adjustment Net Interest Expense
AdjustedEBITDAAdjustmentNetInterestExpense
24700000 USD
CY2020Q2 ck0001552033 Adjusted Ebitda Adjustment Net Interest Expense
AdjustedEBITDAAdjustmentNetInterestExpense
32300000 USD
ck0001552033 Adjusted Ebitda Adjustment Net Interest Expense
AdjustedEBITDAAdjustmentNetInterestExpense
49800000 USD
ck0001552033 Adjusted Ebitda Adjustment Net Interest Expense
AdjustedEBITDAAdjustmentNetInterestExpense
68100000 USD
CY2021Q2 ck0001552033 Adjusted Ebitda Adjustment Depreciationand Amortization
AdjustedEBITDAAdjustmentDepreciationandAmortization
98400000 USD
CY2020Q2 ck0001552033 Adjusted Ebitda Adjustment Depreciationand Amortization
AdjustedEBITDAAdjustmentDepreciationandAmortization
90800000 USD
ck0001552033 Adjusted Ebitda Adjustment Depreciationand Amortization
AdjustedEBITDAAdjustmentDepreciationandAmortization
192700000 USD
ck0001552033 Adjusted Ebitda Adjustment Depreciationand Amortization
AdjustedEBITDAAdjustmentDepreciationandAmortization
181200000 USD
CY2021Q2 ck0001552033 Adjusted Ebitda Adjustment Stockbased Compensation
AdjustedEBITDAAdjustmentStockbasedCompensation
18100000 USD
CY2020Q2 ck0001552033 Adjusted Ebitda Adjustment Stockbased Compensation
AdjustedEBITDAAdjustmentStockbasedCompensation
19400000 USD
ck0001552033 Adjusted Ebitda Adjustment Stockbased Compensation
AdjustedEBITDAAdjustmentStockbasedCompensation
34400000 USD
ck0001552033 Adjusted Ebitda Adjustment Stockbased Compensation
AdjustedEBITDAAdjustmentStockbasedCompensation
21700000 USD
CY2021Q2 ck0001552033 Adjusted Ebitda Adjustment Mergersand Acquisition
AdjustedEBITDAAdjustmentMergersandAcquisition
11300000 USD
CY2020Q2 ck0001552033 Adjusted Ebitda Adjustment Mergersand Acquisition
AdjustedEBITDAAdjustmentMergersandAcquisition
7100000 USD
ck0001552033 Adjusted Ebitda Adjustment Mergersand Acquisition
AdjustedEBITDAAdjustmentMergersandAcquisition
13100000 USD
ck0001552033 Adjusted Ebitda Adjustment Mergersand Acquisition
AdjustedEBITDAAdjustmentMergersandAcquisition
11500000 USD
CY2021Q2 ck0001552033 Adjusted Ebitda Adjustment Accelerated Technology
AdjustedEBITDAAdjustmentAcceleratedTechnology
9800000 USD
CY2020Q2 ck0001552033 Adjusted Ebitda Adjustment Accelerated Technology
AdjustedEBITDAAdjustmentAcceleratedTechnology
3300000 USD
ck0001552033 Adjusted Ebitda Adjustment Accelerated Technology
AdjustedEBITDAAdjustmentAcceleratedTechnology
17100000 USD
ck0001552033 Adjusted Ebitda Adjustment Accelerated Technology
AdjustedEBITDAAdjustmentAcceleratedTechnology
5800000 USD
CY2021Q2 ck0001552033 Adjusted Ebitda Adjustment Other
AdjustedEBITDAAdjustmentOther
33900000 USD
CY2020Q2 ck0001552033 Adjusted Ebitda Adjustment Other
AdjustedEBITDAAdjustmentOther
1800000 USD
ck0001552033 Adjusted Ebitda Adjustment Other
AdjustedEBITDAAdjustmentOther
33800000 USD
ck0001552033 Adjusted Ebitda Adjustment Other
AdjustedEBITDAAdjustmentOther
33800000 USD
CY2021Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
5200000 USD
CY2020Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1500000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
8000000.0 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
5600000 USD
CY2021Q2 ck0001552033 Adjusted Ebitda Adjustment Total
AdjustedEBITDAAdjustmentTotal
151100000 USD
CY2020Q2 ck0001552033 Adjusted Ebitda Adjustment Total
AdjustedEBITDAAdjustmentTotal
177400000 USD
ck0001552033 Adjusted Ebitda Adjustment Total
AdjustedEBITDAAdjustmentTotal
321700000 USD
ck0001552033 Adjusted Ebitda Adjustment Total
AdjustedEBITDAAdjustmentTotal
369900000 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
195400000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
93000000.0 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
353500000 USD
CY2021Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
46700000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
189600000 USD
CY2020Q2 us-gaap Unrealized Loss On Securities
UnrealizedLossOnSecurities
4800000 USD
CY2020Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
2500000 USD
us-gaap Unrealized Loss On Securities
UnrealizedLossOnSecurities
4800000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
2500000 USD
ck0001552033 Reimbursement
Reimbursement
100000 USD
CY2021Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
1900000 USD
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
2000000.0 USD
CY2020Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
1800000 USD
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
3300000 USD
CY2021Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2700000 USD
CY2020Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2100000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
5700000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
4600000 USD
us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
Contingencies<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal and Regulatory Matters</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are routinely named as defendants in, or parties to, various legal actions and proceedings relating to our current or past business operations. These actions generally assert claims for violations of federal or state credit reporting, consumer protection or privacy laws, or common law claims related to the unfair treatment of consumers, and may include claims for substantial or indeterminate compensatory or punitive damages, or injunctive relief, and may seek business practice changes. We believe that most of these claims are either without merit or we have valid defenses to the claims, and we vigorously defend these matters or seek non-monetary or small monetary settlements, if possible. However, due to the uncertainties inherent in litigation, we cannot predict the outcome of each claim in each instance.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, we also are subject to governmental and regulatory examinations, information-gathering requests, investigations and proceedings (both formal and informal), certain of which may result in adverse judgments, settlements, fines, penalties, injunctions or other relief. In connection with formal and informal inquiries by these regulators, we routinely receive requests, subpoenas and orders seeking documents, testimony, and other information in connection with various aspects of our activities.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In view of the inherent unpredictability of legal and regulatory matters, particularly where the damages sought are substantial or indeterminate or when the proceedings or investigations are in the early stages, we cannot determine with any degree of certainty the timing or ultimate resolution of legal and regulatory matters or the eventual loss, fines or penalties, if any, that may result from such matters. We establish reserves for legal and regulatory matters when those matters present loss contingencies that are both probable and can be reasonably estimated. However, for certain of the matters described below, we are not able to reasonably estimate our exposure because damages have not been specified and (i) the proceedings are in early stages, (ii) there is uncertainty as to the likelihood of a class being certified or the ultimate size of the class, (iii) there is uncertainty as to the outcome of similar matters pending against our competitors, (iv) there are significant factual issues to be resolved, and/or (v) there are legal issues of a first impression being presented. The actual costs of resolving legal and regulatory matters, however, may be substantially higher than the amounts reserved for those matters, and an adverse outcome in certain of these matters could have a material adverse effect on our consolidated financial statements in particular quarterly or annual periods. We accrue amounts for certain legal and regulatory matters for which losses are considered to be probable of occurring based on our best estimate of the most likely outcome. It is reasonably possible actual losses could be significantly different from our current estimates. In addition, there are some matters for which it is reasonably possible that a loss will occur, however we cannot estimate a range of the potential losses for these matters. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To reduce our exposure to an unexpected significant monetary award resulting from an adverse judicial decision, we maintain insurance that we believe is appropriate and adequate based on our historical experience. We regularly advise our insurance carriers of the claims (threatened or pending) against us in the course of litigation and generally receive a reservation of rights letter from the carriers when such claims exceed applicable deductibles. We are not aware of any significant monetary claim that has been asserted against us in the course of pending litigation that would not have some level of coverage by insurance after the relevant deductible, if any, is met.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2021 and December 31, 2020, we have accrued liabilities of $46.7 million and $76.0 million, respectively, for anticipated claims. These amounts are included in other accrued liabilities in the consolidated balance sheets. Litigation expense is included in selling, general and administrative expenses in the consolidated statements of income. Legal fees incurred in connection with ongoing litigation and enforcement matters are considered period costs and are expensed as incurred.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion describes material developments in previously disclosed material legal and regulatory matters that occurred in the six months ended June 30, 2021. Refer to Part II, Item 8, Footnote 20, “Contingencies” of our Annual Report on Form 10-K for the year ended December 31, 2020, for a full description of our material pending legal and regulatory matters at that time.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Ramirez v. Trans Union LLC</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of a decision by the United States Third Circuit Court of Appeals (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cortez v. Trans Union LLC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) in 2010, we modified one of our add-on services we offer to our business customers that was designed to alert our customer that the consumer, who was seeking to establish a business relationship with the customer, may potentially be on the Office of Foreign Assets Control, Specifically Designated National and Blocked Persons alert list (the “OFAC Alert”). </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ramirez v. Trans Union LLC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (“Ramirez” or the “Ramirez Litigation”) filed in 2012, the plaintiff alleged that the OFAC Alert service did not comply with the Cortez ruling and that we willfully violated the Fair Credit Reporting Act (“FCRA”) by continuing to offer the OFAC Alert service. The plaintiff also alleged that there are one or more classes of individuals who should be entitled to statutory damages based on the allegedly willful violations. In July 2014, the trial Court in Ramirez certified a class of 8,185 individuals solely for purposes of statutory damages if TransUnion was ultimately found to have willfully violated the FCRA. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 21, 2017, the jury in Ramirez returned a verdict in favor of a class of 8,185 individuals and awarded punitive and statutory damages totaling approximately $60 million. In November 2017, the trial court denied our post-trial motions for judgment as a matter of law, a new trial and a reduction on the jury verdict.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We appealed the Ramirez ruling to the United States Court of Appeals for the Ninth Circuit and on February 27, 2020, the Ninth Circuit affirmed in part and reversed and vacated in part the trial court’s judgment, holding that the punitive damages award was excessive in violation of constitutional due process. On April 8, 2020, the Ninth Circuit denied our petition for rehear</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">en banc, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and on September 2, 2020, we filed a Petition for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certiorari </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with the United States Supreme Court. On December 16, 2020, the United States Supreme Court granted the Petition for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certiorari</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> with respect to whether Article III of the United States Constitution or Rule 23 of the Federal Rules of Civil Procedure permit a damages class action where the vast majority of the class suffered no actual injury, let alone an injury anything like what the class representative suffered.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 25, 2021, the United States Supreme Court’s decision reversed the Ninth Circuit opinion, and remanded the matter back to the lower courts for further proceedings consistent with its opinion. The United States Supreme Court’s opinion held that only plaintiffs who have suffered a concrete harm by a defendant’s statutory violation have Article III standing to seek damages against defendants in Federal court. Based on the ruling, only approximately 23% of the class was determined to have suffered concrete harm. Accordingly, as of June 30, 2021, we revised the amount of the probable loss that we previously estimated, resulting in a reduction of our estimated liability and partially offsetting insurance receivable, with a $32.4 million net reduction recorded in selling, general and administrative expense. We also recorded a related income tax expense of $8.1 million in our provision for income taxes.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CFPB Matter</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, we received a Notice and Opportunity to Respond and Advise (“NORA”) letter from the Consumer Financial Protection Bureau (“CFPB”), informing us that the CFPB’s Enforcement Division is considering whether to recommend that the CFPB take legal action against us and certain of our executive officers. The NORA letter alleges that we failed to comply with and timely implement a Consent Order issued by the CFPB in January 2017, and further alleges additional violations related to Consumer Interactive’s marketing practices. We continue to believe that our marketing practices are lawful and appropriate. Should the CFPB commence an action against us, it may seek restitution, civil monetary penalties, injunctive relief or other corrective action. We cannot provide assurance that the CFPB will not ultimately commence a legal action against us in this matter, nor are we able to predic</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">t the likely outcome of this matter. As of June 30, 2021, the amount of the probable loss is not reasonably estimable.</span></div>
CY2020Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
76000000.0 USD

Files In Submission

Name View Source Status
0001552033-21-000046-index-headers.html Edgar Link pending
0001552033-21-000046-index.html Edgar Link pending
0001552033-21-000046.txt Edgar Link pending
0001552033-21-000046-xbrl.zip Edgar Link pending
ck0001552033-20210630.htm Edgar Link pending
ck0001552033-20210630.xsd Edgar Link pending
ck0001552033-20210630_cal.xml Edgar Link unprocessable
ck0001552033-20210630_def.xml Edgar Link unprocessable
ck0001552033-20210630_htm.xml Edgar Link completed
ck0001552033-20210630_lab.xml Edgar Link unprocessable
ck0001552033-20210630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tu-20210630ex311.htm Edgar Link pending
tu-20210630ex312.htm Edgar Link pending
tu-20210630ex32.htm Edgar Link pending